Paper
Dose-Ranging Efficacy and Safety Study of Albuterol Multidose Dry Powder Inhaler (MDPI) vs Albuterol Hydrofluoroalkane (HFA) and Placebo MDPI in Children With Asthma
Published Feb 1, 2016 · P. Qaqundah, H. Taveras, H. Iverson
The Journal of Allergy and Clinical Immunology
0
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
RCT
Rigorous JournalStudy Snapshot
Albuterol MDPI significantly improves pulmonary function in children with asthma, with similar effects to albuterol HFA, and its safety profile is consistent with that of albuterol HFA.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···